Troglitazone improves Psoriasis and normalizes models of proliferative skin disease : Ligands for Peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation
- Author
- ELLIS, C. N1 ; VARANI, J2 ; FISHER, G. J1 ; ZEIGLER, M. E2 ; PERSHADSINGH, H. A3 4 ; BENSON, S. C5 ; YIQING CHI2 ; KURTZ, T. W6
[1] Department of Dermatology, University of Michigan Medical School, Ann Arbor, United States
[2] Department of Pathology, University of Michigan Medical School, Ann Arbor, United States
[3] Department of Family Medicine, University of California, Irvine, United States
[4] Kern Medical Center, Bakersfield, Calif, United States
[5] Department of Biological Sciences, California State University, Hayward, United States
[6] Department of Laboratory Medicine, University of California, San Francisco, United States - Source
Archives of dermatology (1960). 2000, Vol 136, Num 5, pp 609-616 ; ref : 50 ref
- CODEN
- ARDEAC
- ISSN
- 0003-987X
- Scientific domain
- Dermatology
- Publisher
- American Medical Association, Chicago, IL
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Activité biologique Antipsoriasique Chimiothérapie Etude cas Homme Kératinocyte Multiplication cellulaire Proliférateur peroxysome Psoriasis Traitement Troglitazone Thiazolidinedione dérivé Peau pathologie
- Keyword (en)
- Biological activity Antipsoriatic agent Chemotherapy Case study Human Keratinocyte Cell proliferation Peroxisome proliferator Psoriasis Treatment Troglitazone Skin disease
- Keyword (es)
- Actividad biológica Antipsoriásico Quimioterapia Estudio caso Hombre Queratinocito Multiplicación celular Proliferador peroxisoma Psoriasis Tratamiento Troglitazona Piel patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02K Skin, nail, hair, dermoskeleton
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B08 Dermatology / 002B08D Psoriasis. Parapsoriasis. Lichen
- Discipline
- Dermatology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1400045
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1001/archderm.136.5.609 
https://dx.doi.org/10.1001/archderm.136.5.609
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archderm.136.5.609\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:178:\"Troglitazone improves Psoriasis and normalizes models of proliferative skin disease : Ligands for Peroxisome proliferator-activated receptor-\u03b3 inhibit keratinocyte proliferation\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Archives of dermatology (1960)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Arch. dermatol. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:3:\"136\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"609\";s:8:\"\u0000*\u0000epage\";s:3:\"616\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-987X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ELLIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. N\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:9:\"VARANI, J\";i:1;s:12:\"FISHER, G. J\";i:2;s:13:\"ZEIGLER, M. E\";i:3;s:18:\"PERSHADSINGH, H. A\";i:4;s:12:\"BENSON, S. C\";i:5;s:10:\"YIQING CHI\";i:6;s:11:\"KURTZ, T. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARDEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:178:\"Troglitazone improves Psoriasis and normalizes models of proliferative skin disease : Ligands for Peroxisome proliferator-activated receptor-\u03b3 inhibit keratinocyte proliferation\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archderm.136.5.609\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:178:\"Troglitazone improves Psoriasis and normalizes models of proliferative skin disease : Ligands for Peroxisome proliferator-activated receptor-\u03b3 inhibit keratinocyte proliferation\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Archives of dermatology (1960)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Arch. dermatol. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:3:\"136\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"609\";s:8:\"\u0000*\u0000epage\";s:3:\"616\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-987X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ELLIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. N\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:9:\"VARANI, J\";i:1;s:12:\"FISHER, G. J\";i:2;s:13:\"ZEIGLER, M. E\";i:3;s:18:\"PERSHADSINGH, H. A\";i:4;s:12:\"BENSON, S. C\";i:5;s:10:\"YIQING CHI\";i:6;s:11:\"KURTZ, T. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARDEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:178:\"Troglitazone improves Psoriasis and normalizes models of proliferative skin disease : Ligands for Peroxisome proliferator-activated receptor-\u03b3 inhibit keratinocyte proliferation\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archderm.136.5.609\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archderm.136.5.609\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:178:\"Troglitazone improves Psoriasis and normalizes models of proliferative skin disease : Ligands for Peroxisome proliferator-activated receptor-\u03b3 inhibit keratinocyte proliferation\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Archives of dermatology (1960)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Arch. dermatol. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:3:\"136\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"609\";s:8:\"\u0000*\u0000epage\";s:3:\"616\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-987X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ELLIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. N\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:9:\"VARANI, J\";i:1;s:12:\"FISHER, G. J\";i:2;s:13:\"ZEIGLER, M. E\";i:3;s:18:\"PERSHADSINGH, H. A\";i:4;s:12:\"BENSON, S. C\";i:5;s:10:\"YIQING CHI\";i:6;s:11:\"KURTZ, T. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARDEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:178:\"Troglitazone improves Psoriasis and normalizes models of proliferative skin disease : Ligands for Peroxisome proliferator-activated receptor-\u03b3 inhibit keratinocyte proliferation\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1001\/archderm.136.5.609\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:178:\"Troglitazone improves Psoriasis and normalizes models of proliferative skin disease : Ligands for Peroxisome proliferator-activated receptor-\u03b3 inhibit keratinocyte proliferation\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Archives of dermatology (1960)\";s:9:\"\u0000*\u0000stitle\";s:22:\"Arch. dermatol. (1960)\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:3:\"136\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"609\";s:8:\"\u0000*\u0000epage\";s:3:\"616\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-987X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ELLIS\";s:10:\"\u0000*\u0000aufirst\";s:4:\"C. N\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:9:\"VARANI, J\";i:1;s:12:\"FISHER, G. J\";i:2;s:13:\"ZEIGLER, M. E\";i:3;s:18:\"PERSHADSINGH, H. A\";i:4;s:12:\"BENSON, S. C\";i:5;s:10:\"YIQING CHI\";i:6;s:11:\"KURTZ, T. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARDEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:178:\"Troglitazone improves Psoriasis and normalizes models of proliferative skin disease : Ligands for Peroxisome proliferator-activated receptor-\u03b3 inhibit keratinocyte proliferation\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
